0.048
price up icon48.61%   0.0157
after-market Handel nachbörslich: .05 0.002 +4.17%
loading

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

pulisher
Apr 04, 2026

IOBT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

Why are shares of IO Biotech plummeting? - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Benzinga

Apr 03, 2026
pulisher
Apr 03, 2026

Layoff Tracker: Gilead Lays Off Employees at California Headquarters - BioSpace

Apr 03, 2026
pulisher
Apr 02, 2026

The rollercoaster ride stopps and danish IO Biotech goes bust - European Biotechnology Magazine

Apr 02, 2026
pulisher
Apr 02, 2026

Earnings Beat: What is the long term forecast for IO Biotech Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 01, 2026

IOBT SEC FilingsIo Biotech, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

IO Biotech, Inc. Files Form 8-K With SEC – Company Information, Stock Details, and Regulatory Compliance (March 31, 2026) - Minichart

Mar 31, 2026
pulisher
Mar 31, 2026

Cancer Vaccine Developer Files Ch. 7 After Trials Fall Short - Law360

Mar 31, 2026
pulisher
Mar 31, 2026

IO Biotech Files Chapter 7, Ceases Operations, Liquidates - TipRanks

Mar 31, 2026
pulisher
Mar 31, 2026

Why Are Shares Of IO Biotech Plummeting? - Benzinga

Mar 31, 2026
pulisher
Mar 31, 2026

Io Biotech Incfiles voluntary chapter 7 bankruptcy petition on March 31, 2026SEC filing - MarketScreener

Mar 31, 2026
pulisher
Mar 31, 2026

IO Biotech (IOBT) shuts down and files for Chapter 7 liquidation - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech

Mar 31, 2026
pulisher
Mar 26, 2026

Aug Swings: Will IO Biotech Inc outperform its industry peersRisk Management & Stepwise Swing Trade Plans - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Big Money Moves: Will IO Biotech Inc outperform tech stocksExit Point & Short-Term Trading Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Insider Trends: Whats the outlook for Samfine Creation Holdings Group Limiteds sectorTrade Risk Assessment & AI Forecasted Stock Moves - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 23, 2026

IO Biotech (IOBT) to Release Quarterly Earnings on Monday - Defense World

Mar 23, 2026
pulisher
Mar 18, 2026

Is Haverty Furniture Companies Inc part of any major index2026 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Here's why IO Biotech, Inc. (IOBT) looks ripe for bottom fishing - MSN

Mar 18, 2026
pulisher
Mar 10, 2026

IOBT Stock Price and Chart — NASDAQ:IOBT - TradingView

Mar 10, 2026
pulisher
Mar 07, 2026

IOBT Earnings History & Surprises | EPS & Revenue Results | IO BIOTECH INC (NASDAQ:IOBT) - ChartMill

Mar 07, 2026
pulisher
Mar 06, 2026

Market Overview: Is IO Biotech Inc stock a smart retirement pickEarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 02, 2026

IO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decline in Short Interest - Defense World

Mar 02, 2026
pulisher
Feb 28, 2026

IOBT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026
pulisher
Feb 28, 2026

IOBT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Portfolio Update: Is IO Biotech Inc stock a smart retirement pick2025 Support & Resistance & Consistent Profit Trading Strategies - baoquankhu1.vn

Feb 27, 2026
pulisher
Feb 24, 2026

IO Biotech receives Nasdaq notice for bid price noncompliance - MSN

Feb 24, 2026
pulisher
Feb 20, 2026

Is IO Biotech Inc. stock attractive for ETFs2025 Earnings Surprises & Low Risk Entry Point Tips - mfd.ru

Feb 20, 2026
pulisher
Feb 18, 2026

Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ DrugsCollaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech - Yahoo Finance

Feb 18, 2026
pulisher
Feb 16, 2026

Will IO Biotech Inc. outperform its industry peers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru

Feb 16, 2026
pulisher
Feb 15, 2026

Chart Watch: Will IO Biotech Inc outperform tech stocksBuy Signal & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 14, 2026

IOBT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 14, 2026
pulisher
Feb 14, 2026

IOBT PE Ratio & Valuation, Is IOBT Overvalued - Intellectia AI

Feb 14, 2026
pulisher
Feb 14, 2026

IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk - The Globe and Mail

Feb 14, 2026
pulisher
Feb 13, 2026

IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule - Stock Titan

Feb 13, 2026
pulisher
Feb 13, 2026

Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing - Finviz

Feb 13, 2026
pulisher
Feb 12, 2026

Is IO Biotech Inc. a top pick in the sectorJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 06, 2026

Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Point72 discloses 5.6% IO Biotech (IOBT) ownership stake - Stock Titan

Feb 06, 2026
pulisher
Feb 02, 2026

IO Biotech Provides Corporate Update - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World

Feb 02, 2026
pulisher
Jan 30, 2026

IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan

Jan 30, 2026
pulisher
Jan 30, 2026

IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada

Jan 30, 2026
pulisher
Jan 30, 2026

IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative

Jan 30, 2026
pulisher
Jan 30, 2026

Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan

Jan 30, 2026
pulisher
Jan 27, 2026

Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance

Jan 27, 2026
pulisher
Jan 26, 2026

IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa

Jan 26, 2026
pulisher
Jan 26, 2026

IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa

Jan 26, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):